Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 120.54B | 118.43B | 114.73B | 117.07B | 110.47B | 102.72B |
Gross Profit | 53.88B | 52.95B | 49.77B | 45.95B | 43.28B | 40.72B |
EBITDA | 41.28B | 40.62B | 38.22B | 34.23B | 34.41B | 32.94B |
Net Income | 12.60B | 11.21B | 17.79B | 8.00B | 4.18B | 4.16B |
Balance Sheet | ||||||
Total Assets | 281.51B | 304.93B | 290.31B | 298.59B | 281.63B | 264.92B |
Cash, Cash Equivalents and Short-Term Investments | 15.17B | 8.37B | 7.28B | 5.62B | 6.01B | 12.94B |
Total Debt | 136.96B | 145.15B | 138.75B | 147.75B | 142.07B | 137.26B |
Total Liabilities | 191.78B | 206.29B | 199.07B | 211.27B | 200.16B | 192.37B |
Stockholders Equity | 58.91B | 63.30B | 56.92B | 48.56B | 42.68B | 35.92B |
Cash Flow | ||||||
Free Cash Flow | 21.12B | 20.70B | 19.43B | 11.71B | 5.81B | 5.05B |
Operating Cash Flow | 40.92B | 39.87B | 37.30B | 35.82B | 32.17B | 23.74B |
Investing Cash Flow | -19.20B | -18.90B | -10.21B | -22.31B | -27.40B | -22.65B |
Financing Cash Flow | -18.93B | -20.28B | -25.53B | -15.44B | -10.78B | 7.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $172.03B | 9.48 | 18.26% | 6.76% | 2.05% | 61.39% | |
74 Outperform | $170.40B | 12.57 | 20.81% | 2.85% | 4.64% | 156.88% | |
73 Outperform | $258.95B | 21.70 | 19.74% | 1.54% | 6.27% | 31.78% | |
70 Outperform | $186.63B | 14.88 | 12.12% | 4.26% | 1.46% | 0.88% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
56 Neutral | $30.02B | ― | -3.55% | 6.29% | -4.73% | -251.31% | |
54 Neutral | $27.83B | ― | -7.17% | 4.30% | 0.89% | -494.16% |